Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of Filgotinib in Perianal Fistulizing Crohn's Disease
2016-003153-15Phase 2Unknown
- Sponsor
- Gilead Sciences
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of filgotinib in Crohn's disease, sponsored by Gilead Sciences. Status: unknown.
02
Drugs
filgotinib
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2016-003153-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003153-15.